Free tool
Stocks listed on XETRA
We cover 103 companies listed on XETRA. The median market value in the group is $15.96B. Across the group, the median move over the past trading day is −0.18%. 60% of the 95 with a 200-day average trade above it. Price change over the past year runs from −44.5% to +61.1% across the middle 80 percent of the group, with a median of +2.9%.
Other lists in this group
Table
103 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.12T | Mega cap | +68.40% |
| JNJ.DE | Johnson & Johnson | $659.04B | Mega cap | +54.31% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +29.69% |
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% |
| RHO.DE | Roche Holding AG | $377.17B | Mega cap | +39.70% |
| NOT.DE | NOVARTIS AG N | $303.40B | Mega cap | +27.82% |
| AMG.DE | Amgen Inc. | $241.28B | Mega cap | +56.55% |
| TN8.DE | Thermo Fisher Scientific Inc. | $231.85B | Mega cap | +27.50% |
| NOV.DE | Novo Nordisk A/S | $213.87B | Mega cap | +11.69% |
| ABL.DE | Abbott Laboratories | $200.83B | Mega cap | −9.70% |
| GIS.DE | Gilead Sciences, Inc. | $183.56B | Large cap | +29.53% |
| PFE.DE | Pfizer Inc. | $162.65B | Large cap | +18.09% |
| DAP.DE | Danaher Corporation | $151.41B | Large cap | +5.45% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $140.77B | Large cap | +40.14% |
| BRM.DE | Bristol-Myers Squibb Company | $138.39B | Large cap | +46.24% |
| IUI1.DE | Intuitive Surgical, Inc. | $133.35B | Large cap | −20.90% |
| SYK.DE | STRYKER CORP. R | $126.48B | Large cap | +34.76% |
| 2M6.DE | Medtronic plc | $117.39B | Large cap | +3.67% |
| SNW.DE | Sanofi | $109.49B | Large cap | −4.28% |
| GS71.DE | GSK plc | $104.54B | Large cap | +31.93% |
| A58.DE | Elevance Health, Inc. | $86.73B | Large cap | −18.92% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $86.30B | Large cap | −7.35% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.86B | Large cap | −38.59% |
| CGN.DE | The Cigna Group | $73.25B | Large cap | −8.36% |
| BSX.DE | Boston Scientific Corporation | $71.57B | Large cap | −54.21% |
| MRK.DE | Merck KGaA | $70.75B | Large cap | +30.60% |
| 0QF.DE | Moderna, Inc. | $63.46B | Large cap | +461.14% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.51B | Large cap | +71.10% |
| BOX.DE | Becton, Dickinson and Company | $52.05B | Large cap | +2.94% |
| EWL.DE | Edwards Lifesciences Corporation | $51.93B | Large cap | +10.23% |
| SHL.DE | Siemens Healthineers AG | $51.88B | Large cap | −12.35% |
| H6D0.DE | Haleon plc | $44.53B | Large cap | +4.86% |
| IX1.DE | IDEXX Laboratories, Inc. | $43.12B | Large cap | +17.97% |
| QTS.DE | IQVIA Holdings Inc. | $42.69B | Large cap | −3.91% |
| VEE.DE | Veeva System Inc. R | $40.06B | Large cap | +13.96% |
| 2U3.DE | Alcon Inc. | $35.35B | Large cap | −10.05% |
| DC4.DE | DexCom, Inc. | $34.19B | Large cap | +21.55% |
| ILU.DE | Illumina, Inc. | $34.04B | Large cap | +119.28% |
| IDP.DE | Biogen Inc. | $32.80B | Large cap | +57.35% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $31.87B | Large cap | −11.75% |
| ZOE.DE | Zoetis Inc. | $31.72B | Large cap | −50.09% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.15B | Large cap | +1.55% |
| 22UA.DE | BioNTech SE | $29.53B | Large cap | +8.53% |
| MTO.DE | Mettler-Toledo International Inc. | $27.84B | Large cap | +13.15% |
| PHI1.DE | Koninklijke Philips N.V. | $26.73B | Large cap | +2.84% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $22.06B | Large cap | +10.46% |
| GE9.DE | GENMAB AS N | $21.11B | Large cap | −14.41% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.88B | Large cap | +26.10% |
| VIA.DE | Viatris Inc. | $19.14B | Large cap | +62.09% |
| QS51.DE | Straumann Holding AG | $18.25B | Large cap | +0.41% |
| CBHD.DE | Coloplast A/S | $16.19B | Large cap | +7.28% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.72B | Large cap | +22.06% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| FME.DE | Fresenius Medical Care AG | $12.66B | Large cap | −3.50% |
| AFW.DE | Align Technology, Inc. | $11.31B | Large cap | −54.37% |
| WDH1.DE | Demant A/S | $9.39B | Mid cap | −5.53% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| OBCK.DE | Ottobock SE & Co. KGaA I | $4.51B | Mid cap | −0.82% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.04B | Mid cap | −0.90% |
| BBZA.DE | BB Biotech AG | $3.90B | Mid cap | +7.22% |
| FIE.DE | Fielmann Group AG | $3.85B | Mid cap | −30.39% |
| AFX.DE | Carl Zeiss Meditec AG | $3.26B | Mid cap | −23.23% |
| B72.DE | AtaiBeckley Inc. | $2.60B | Mid cap | +57.16% |
| BV3.DE | BAVARIAN NORDIC N | $2.59B | Mid cap | +14.47% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.44B | Mid cap | +63.50% |
| DMP.DE | Dermapharm Holding SE | $2.43B | Mid cap | +14.86% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.89B | Small cap | −44.50% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.81B | Small cap | +52.14% |
| RDC.DE | Redcare Pharmacy NV | $1.46B | Small cap | −31.39% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.15B | Small cap | +27.68% |
| GXI.DE | Gerresheimer AG | $1.03B | Small cap | −33.73% |
| EUZ.DE | Eckert & Ziegler SE | $963.05M | Small cap | −23.06% |
| EVT.DE | Evotec SE | $675.17M | Small cap | −44.85% |
| AYJ.DE | Valneva SE | $659.69M | Small cap | −25.10% |
| 2HQ0.DE | Tilray Brands, Inc. | $653.85M | Small cap | −66.96% |
| M12.DE | M1 Kliniken AG | $402.58M | Small cap | +34.56% |
| FYB.DE | Formycon AG | $380.53M | Small cap | −19.75% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | $327.98M | Small cap | +40.74% |
| ILM1.DE | Medios AG | $325.22M | Small cap | −27.36% |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% |
| MED.DE | MEDICLIN Aktiengesellschaft | $302.28M | Small cap | +83.33% |
| IDD.DE | Innate Pharma S.A. | $247.30M | Small cap | −2.52% |
| LIK.DE | LIMES Schlosskliniken AG | $198.31M | Small cap | +72.16% |
| VME.DE | Viromed Medical AG N | $161.29M | Small cap | +96.93% |
| HPHA.DE | Heidelberg Pharma AG | $137.67M | Small cap | −44.40% |
| 88Q.DE | 4basebio PLC | $96.74M | Micro cap | −46.70% |
| 7V0.DE | Novogenia AG | $89.68M | Micro cap | −29.07% |
| HIGH.DE | Cantourage Group SE | $83.91M | Micro cap | +45.19% |
| AJ91.DE | DocCheck AG | $64.58M | Micro cap | −9.24% |
| V3V.DE | FamiCord AG | $58.21M | Micro cap | −60.69% |
| M3V.DE | MeVis Medical Solutions AG | $50.58M | Micro cap | −0.42% |
| BXT.DE | BioNxt Solutions Inc. | $34.95M | Micro cap | −66.30% |
| NN6.DE | NanoRepro AG | $27.17M | Micro cap | −6.09% |
| PSH0.DE | Sernova Biotherapeutics Inc | $26.97M | Micro cap | −46.78% |
| AAQ1.DE | aap Implantate AG | $25.09M | Micro cap | −12.57% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | $22.53M | Micro cap | −21.85% |
| B8FK.DE | Biofrontera AG | $17.95M | Micro cap | −4.55% |
| GME.DE | Geratherm Medical AG | $16.30M | Micro cap | −17.15% |
| SBX.DE | SynBiotic SE | $6.25M | Micro cap | −76.94% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| 27N0.DE | CANNOVUM CANNABIS AG I | $1.50M | Micro cap | +4.36% |
| PTP.DE | Pentixapharm Holding AG N | $1.08M | Micro cap | +8.55% |
| T9G.DE | Vidac Pharma Holding Plc | — | — | −37.21% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.